Navigation Links
Varian Medical Systems to Unveil RapidArc(TM) Volumetric Arc Therapy and Other Products Designed to Speed Delivery of Precision Radiotherapy and Brachytherapy
Date:10/25/2007

Products to be exhibited at the 2007 American Society for Therapeutic Radiology and Oncology (ASTRO) meeting in Los Angeles, California, Oct 28 -

Oct 31

PALO ALTO, Calif., Oct. 25 /PRNewswire-FirstCall/ -- ASTRO Booth # 419 -- Varian Medical Systems (NYSE: VAR), world leader in advanced radiotherapy solutions for treating cancer and other disorders, will unveil a faster and more precise technology for treating cancer patients with intensity modulated radiotherapy (IMRT) at the 49th annual meeting of the American Society for Therapeutic Radiology and Oncology in Los Angeles next week. Varian's ASTRO exhibit will feature its groundbreaking RapidArc(TM) radiotherapy technology* among several products that are designed to increase the speed, precision, and personalization of cancer treatments.

Varian's ASTRO Booth #419 will highlight:

-- RapidArc(TM) radiotherapy*, a new volumetric arc therapy that will enable clinicians to deliver radiation more precisely in much less time. RapidArc will make it possible to quickly deliver a complete intensity- modulated radiation treatment during a single rotation of the treatment machine around the patient while potentially conforming dose more closely to the size, shape and location of the tumor and sparing more surrounding healthy tissue. (See related press release entitled Varian Medical Systems to Introduce RapidArc(TM) Radiotherapy Technology for Volumetric Arc Therapy at ASTRO 2007).

-- The new Novalis(R) Tx radiosurgery offering, combining Varian's high- definition HD120 multileaf collimator, Trilogy(TM) linear accelerator, On- Board Imager(R) device and software with BrainLAB's ExacTrac(TM) imager, robotic couch and tr
'/>"/>

SOURCE Varian Medical Systems, Inc.
Copyright©2007 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2 3 4

Related medicine news :

1. Ovarian cancer in relationship with Hormone therapy
2. Vitamin D Reduces Chances of Colon, Breast And Ovarian Cancers by 50%
3. Progestin protects against ovarian cancer
4. Inherited gene important in ovarian cancer
5. Blood test may identify ovarian cancer
6. Exercise lowers Risk of Ovarian Cancer
7. Screening device for ovarian cancer
8. Ethnic discrepancy in ovarian cancer
9. Gene variant foretells diabetic neuropathy
10. Associated scan for detecting ovarian cancer spread
11. Gene Mutation Causes Ovarian Failure
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/14/2008)... Also debuts TMR,09 campaign, IRVINE, Calif., O...poration (Pink Sheets: CGCP), a global leader of i...nd the market leader of surgical products for,tran...educational symposium,yesterday in conjunction wit...rapeutics (TCT) meeting in Washington, D.C., The ...
(Date:10/14/2008)... more than 500 accounts Company opening new PROMUS...ICK, Mass., Oct. 14 /PRNewswire-FirstCall/ -- Bost...unced estimated U.S. market shares for,September f...liminary data,from Millennium Research Group (MRG)...he healthcare sector., Based on the MRG data, the...
(Date:10/14/2008)... Leading Supplemental Insurance Company Encour... Employee Benefits , Chic...e , a leading provider of supplemental insurance, ...time to review employee benefits and recommends ,V...to help retain employees. These programs can be a ...
(Date:10/14/2008)...ctober 14 /PRNewswire/ -- Researchers at the Insti... started work on a 3.5 year,project to develop a n...hemical vapour deposition) diamond manufactured by...he field of CVD diamond synthesis and its,applicat...uld open up a raft of new,application areas in, fo...
Breaking Medicine News(10 mins):Health News:Cardiogenesis Announces Successful Educational Symposium Targeted at Cardiologists at the TCT Meeting in Washington, D.C. 2Health News:Cardiogenesis Announces Successful Educational Symposium Targeted at Cardiologists at the TCT Meeting in Washington, D.C. 3Health News:Cardiogenesis Announces Successful Educational Symposium Targeted at Cardiologists at the TCT Meeting in Washington, D.C. 4Health News:Boston Scientific Announces Drug-Eluting Stent Market Share Estimates for September and Third Quarter 2Health News:Boston Scientific Announces Drug-Eluting Stent Market Share Estimates for September and Third Quarter 3Health News:Boston Scientific Announces Drug-Eluting Stent Market Share Estimates for September and Third Quarter 4Health News:Combined Insurance Reports that Voluntary Programs Can Offer Employers a Cost Effective Way to Offer Benefits and Help Retain Employees 2Health News:Combined Insurance Reports that Voluntary Programs Can Offer Employers a Cost Effective Way to Offer Benefits and Help Retain Employees 3Health News:Combined Insurance Reports that Voluntary Programs Can Offer Employers a Cost Effective Way to Offer Benefits and Help Retain Employees 4Health News:Combined Insurance Reports that Voluntary Programs Can Offer Employers a Cost Effective Way to Offer Benefits and Help Retain Employees 5Health News:Novel Solid-State Laser Design Based on Synthetic Diamond From Element Six Opens up New Applications 2Health News:Novel Solid-State Laser Design Based on Synthetic Diamond From Element Six Opens up New Applications 3Health News:Novel Solid-State Laser Design Based on Synthetic Diamond From Element Six Opens up New Applications 4
... by the U.S. National Highway Traffic Safety Admin...titute says that people who talk on cell phones //...ely to crash as compared to those whop focus on dr...in 100 sensor-equipped vehicles, which were involv...
...g to the researchers from the La Jolla Institute f...in mice is found to be very effective against Type...e Control and Prevention in Atlanta, Type 1 diabet...of the 18 million cases of diabetes in the United ...
... about increased risk of birth defects associated ...e drug, commonly given for infertility treatment h...hed that the rate of birth defects associated with...h clomiphene citrate, the first line treatment for...
...udy that analyses many trials together concludes t...d in women under age 60 but has mixed results for ... that Hormone replacement therapy (HRT) may preven...tical analysis of 23 trials with more than 39,000 ...
Other Medicine News:Health News:The Combo Treatment Is Effective to Treat Type 1 Diabetes in Mice 2Health News:Hormone Replacement Therapy Can Reduce Heart attacks On Woman Under 60 2
(Date:10/10/2008)... -- Diplomat Specialty,Pharmacy announced today th...ty Pharmacy to be one of only three sites to parti...tion Study for Multiple Sclerosis (TOP MS)., The ...the benefits of a,specialty pharmacy therapy manag... outcomes. Targeted patient outcomes will include:...
(Date:10/10/2008)...-- TriReme Medical Inc. (TMI),announced today that...e,Europeenne) marking and commercialize in Europe ...in vessel stent system specially designed for use,...he next generation in bifurcation stenting, the,An... the 2.2 million,angioplasty procedures performed ...
(Date:10/9/2008)...ember 2008, BOTHELL, Wash., Oct. 9 /PRNewswire-Fi...nced today the completion of patient enrollment an... to evaluate the safety and,efficacy of its formul...or,the over-the-counter (OTC) market. The Company ...al trial in November 2008. Ibuprofen is an analges...
(Date:10/8/2008)...etics and Chemicals Testing, ASHLAND, Mass., Oct....at results of a recently completed US and European...atTek,s EpiDerm in vitro human skin tissue,equival...nsitivity and,specificity for EpiDerm to be accept...r determining human skin irritation by the Europea...
Breaking Medicine Technology:Diplomat Specialty Pharmacy Tapped by Teva Neuroscience for Therapy Optimization Study for Multiple Sclerosis (TOP MS) 2TriReme Medical Inc. Receives CE Marking for Antares(TM) Coronary Stent System 2SCOLR Pharma Announces Completion of Patient Enrollment and Dosing for Pivotal Clinical Trial Evaluating Extended Release Ibuprofen 2SCOLR Pharma Announces Completion of Patient Enrollment and Dosing for Pivotal Clinical Trial Evaluating Extended Release Ibuprofen 3MatTek's EpiDerm In Vitro Tissues Headed for Validation in Europe 2University of Maryland Baltimore BioPark Signs Gliknik Inc as First Tenant in Its BioInnovation Center in Building Two 2532 1University of Maryland Baltimore BioPark Signs Gliknik Inc as First Tenant in Its BioInnovation Center in Building Two 2532 2Dey L P Settles State of Alabama Pricing Litigation 9349 1Dey L P Settles State of Alabama Pricing Litigation 9349 2Hiemstra Approved to Manufacture Medical Devices in New CER 9345 1Hiemstra Approved to Manufacture Medical Devices in New CER 9345 2Keep a Watchful Eye on Sugary Beverage Consumption 9341 1Keep a Watchful Eye on Sugary Beverage Consumption 9341 2
...SINESS WIRE)--Jun 11, 2007 - Geron,Corporation (Na...earch studies indicating that GRNOPC1, the company...tic for the treatment of,spinal cord injury, evade...sented by Geron scientist Ross Okamura at the Fede... San Diego, the findings,could mean that patients ...
...007-ReGen is pleased to announce that,a review of ..., its,nutraceutical product which the Company beli...e function, was presented today at the,2007 Intern...radise, Queensland, Australia by Dr Marian Kruzel,...e, which is being attended by key opinion leaders,...
Other Medicine Technology:Research Indicates Geron's Human Embryonic Stem Cell-Based,Therapeutic for Spinal Cord Injury Evades Direct Attack by the,Human Immune System 2Research Indicates Geron's Human Embryonic Stem Cell-Based,Therapeutic for Spinal Cord Injury Evades Direct Attack by the,Human Immune System 3Data Showing that ReGen's Colostrinin Supports Healthy Cognitive,Function Presented at the 2007 International Congress on Natural,Medicine in Australia 2
Humerus Fracture Brace indications: , Nonoperative treatment of closed humeral shaft fractures , Postoperative treatment of open humeral shaft fractures , Protection of humeral defects , After rem
The FUNCTIONAL ARM BRACE (FAB) was designed to allow immobilization in multiple positions to make it useful as a functional brace in early rehabilitation., ,Far more than an "Elbow ROM Brace" - the
Controls humeral segments through soft tissue compression while allowing for full range of elbow motion
...This simple concept is the cornerstone of our Town...k the heel with our patent-pending Stablelock Syst...t your patient will experience walking in their TS... and supports the posterior aspect of the leg. Thi...
Medicine Products: